Dear Editor,The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has triggered a COVID-19 pandemic that has caused high morbidity and mortality worldwide.1 COVID-19 vaccines are urgently needed to protect al...Dear Editor,The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has triggered a COVID-19 pandemic that has caused high morbidity and mortality worldwide.1 COVID-19 vaccines are urgently needed to protect all susceptible populations from SARS-CoV-2 infection.Neurofibromatosis type 1(NF1)is a hereditary dominant disease that affects approximately one in every 3000 newborns.展开更多
基金This study was supported by grants from the National Natural Science Foundation of China(82202470,82102344,82172228)the Shanghai Rising Star Program supported by the Science and Technology Commission of Shanghai Municipality(20QA1405600)+5 种基金the Natural Science Foundation of Shanghai(22ZR1422300Innovative research team of high-level local universities in Shanghai(SHSMUZDCX20210400)Clinical Research Plan of SHDC(SHDC2020CR1019B)Shanghai Clinical Research Center of Plastic and Reconstructive Surgery supported by Science and Technology Commission of Shanghai Municipality(Grant No.22MC1940300)Shanghai Municipal Science and Technology Major Project(HS2021SHZX001)Shanghai Science and Technology Committee(21NL2600100,20dz2260100).
文摘Dear Editor,The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has triggered a COVID-19 pandemic that has caused high morbidity and mortality worldwide.1 COVID-19 vaccines are urgently needed to protect all susceptible populations from SARS-CoV-2 infection.Neurofibromatosis type 1(NF1)is a hereditary dominant disease that affects approximately one in every 3000 newborns.
